Statistics found here the category is Demand for treatment for drug use (TDI)

Category	Title
TDI	TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006 Part (i) Percentage distribution by primary drug
TDI	TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2002 to 2006 Part (ii) Numbers of clients by primary drug
TDI	TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2006 in 24 EU Member States Part (i) New clients
TDI	TDI-2. New and all clients entering treatment by primary drug: heroin, cocaine, cannabis, other stimulants, other drugs in 2006 in 24 EU Member States Part (ii) All clients
TDI	TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2006 Part (i) Percentage distribution by primary drug
TDI	TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2006 Part (ii) Numbers of clients by primary drug
TDI	TDI-6. New and all outpatient clients by age group in 2006 for those countries supplying data
TDI	TDI-7. New outpatient clients injecting opioid as primary drug from 2003 to 2006 in 13 countries supplying data
TDI	TDI-11. Clients entering first treatment, all clients entering treatment, total clients in treatment, summary of nine EU countries reporting in 2006 Part (i) Number of clients in treatment
TDI	TDI-11. Clients entering first treatment, all clients entering treatment, total clients in treatment, summary of nine EU countries reporting in 2006 Part (ii) Percentage of clients in treatment with opioids, cannabis or other drugs as primary drugs
TDI	TDI-1. Data sources for data on clients entering treatment in 2006
TDI	TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006 Part (i) Total numbers of new clients entering treatment
TDI	TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006 Part (ii) Total numbers of all clients entering treatment
TDI	TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006 Part (iii) Numbers of treatment units covered for reporting clients entering treatment
TDI	TDI-2. Trends in the number of clients entering treatment and the number of reporting treatment centres, 1996 to 2006 Part (iv) Types of units covered for reporting clients entering treatment
TDI	TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006 Part (i) Percentage of new clients using heroin
TDI	TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006 Part (ii) Percentage of new clients using cocaine
TDI	TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006 Part (iii) Percentage of new clients using stimulants (amphetamines and MDMA)
TDI	TDI-3. Trend of new clients entering treatment by primary drug used, 1993 to 2006 Part (iv) Percentage of new clients using cannabis
TDI	TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (i) Demographics of new clients entering treatment
TDI	TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (ii) Primary drug type used (percent of new clients using) and of those, the percent injecting it
TDI	TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (i) Demographics of all clients entering treatment
TDI	TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (ii) Primary drug type used by clients (percentage of all clients) and of those, the percentage injecting the drug
TDI	TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (iii) Demographics of all men entering treatment
TDI	TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (iv) Demographics of all women entering treatment
TDI	TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (v) Primary drug type used by male clients (percentage of all male clients)
TDI	TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available Part (vi) Primary drug type used by female clients (percentage of all female clients)
TDI	TDI-6. Incidence of treatment demands for drug use: new clients entering treatment in 2006 (rate per 100 000 population)
TDI	TDI-7. Data coverage in 2006 for countries supplying data Part (i) Number of new and all clients entering treatment by type of treatment centre
TDI	TDI-7. Data coverage in 2006 for countries supplying data Part (ii) Number and type of treatment centre
TDI	TDI-8. Amphetamines, ecstasy and other non-cocaine stimulants: primary use among new and all clients entering treatment in 2006 for countries supplying data Part (i) All clients with primary use of stimulants other than cocaine in treatment centres reported for the country
TDI	TDI-8. Amphetamines, ecstasy and other non-cocaine stimulants: primary use among new and all clients entering treatment in 2006 for countries supplying data Part (ii) New clients with primary use of stimulants other than cocaine in treatment centres reported for the country
TDI	TDI-9. Mean age and gender distribution among new and all clients entering outpatient treatment in 2006
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (i) Percentage distribution of new outpatient clients by age group for each primary drug
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (ii) Percentage distribution of new outpatient clients by primary drug for each age group
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (iii) Percentage distribution of all outpatient clients by age group for each primary drug
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (iv) Percentage distribution of all outpatient clients by primary drug for each age group
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (v) Percentage distribution of new inpatient clients by age group for each primary drug
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (vi) Percentage distribution of new inpatient clients by primary drug for each age group
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (vii) Percentage distribution of all inpatient clients by age group for each primary drug
TDI	TDI-10. Age distribution by primary drug of clients entering treatment — EU overall summary in 2006 Part (viii) Percentage distribution of all inpatient clients by primary drug for each age group
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (i) Percentage distribution of new outpatient clients by age at first use for each primary drug
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (ii) Percentage distribution of new outpatient clients by primary drug for age at first use
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (iii) Percentage distribution of all outpatient clients by age at first use for each primary drug
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (iv) Percentage distribution of all outpatient clients by primary drug for age at first use
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (v) Percentage distribution of new inpatient clients by age at first use for each primary drug
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (vi) Percentage distribution of new inpatient clients by primary drug for age at first use
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (vii) Percentage distribution of all inpatient clients by age at first use for each primary drug
TDI	TDI-11. Age at first use of primary drug among clients according to primary drug for which they enter treatment — EU overall summary in 2006 Part (viii) Percentage distribution of all inpatient clients by primary drug for age at first use
TDI	TDI-12. Percentage distribution of educational level for clients entering treatment in 2006 Part (i) New clients entering outpatient treatment
TDI	TDI-12. Percentage distribution of educational level for clients entering treatment in 2006 Part (ii) All clients entering outpatient treatment
TDI	TDI-12. Percentage distribution of educational level for clients entering treatment in 2006 Part (iii) New clients entering inpatient treatment
TDI	TDI-12. Percentage distribution of educational level for clients entering treatment in 2006 Part (iv) All clients entering inpatient treatment
TDI	TDI-13. Percentage distribution of labour status for clients entering treatment in 2006 Part (i) New clients entering outpatient treatment
TDI	TDI-13. Percentage distribution of labour status for clients entering treatment in 2006 Part (ii) All clients entering outpatient treatment
TDI	TDI-13. Percentage distribution of labour status for clients entering treatment in 2006 Part (iii) New clients entering inpatient treatment
TDI	TDI-13. Percentage distribution of labour status for clients entering treatment in 2006 Part (iv) All clients entering inpatient treatment
TDI	TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006 Part (i) New clients entering outpatient treatment
TDI	TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006 Part (ii) All clients entering outpatient treatment
TDI	TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006 Part (iii) New clients entering inpatient treatment
TDI	TDI-14. Percentage distribution of accommodation arrangements (persons with whom the client is living) of clients entering treatment in 2006 Part (iv) All clients entering inpatient treatment
TDI	TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006 Part (i) New clients entering outpatient treatment
TDI	TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006 Part (ii) All clients entering outpatient treatment
TDI	TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006 Part (iii) New clients entering inpatient treatment
TDI	TDI-15. Percentage distribution of living conditions for clients entering treatment in 2006 Part (iv) All clients entering inpatient treatment
TDI	TDI-16. Percentage distribution of source of referral for new clients entering outpatient and inpatient treatment in 2006 Part (i) New clients entering outpatient treatment
TDI	TDI-16. Percentage distribution of source of referral for new clients entering outpatient and inpatient treatment in 2006 Part (ii) New clients entering inpatient treatment
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (i) Percentage distribution of route of administration amongst new clients with opioids as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (ii) Percentage distribution of route of administration amongst new clients with cocaine (HCl and crack) as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (iii) Percentage distribution of route of administration amongst new clients with stimulants (other than cocaine) as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (iv) Percentage distribution of route of administration amongst new clients with hypnotics and sedatives as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (v) Percentage distribution of route of administration amongst all clients with opioids as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (vi) Percentage distribution of route of administration amongst all clients with cocaine (HCl and crack) as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (vii) Percentage distribution of route of administration amongst all clients with stimulants (other than cocaine) as primary drug
TDI	TDI-17. Route of administration of primary drug among new and all outpatient clients in 2006 Part (viii) Percentage distribution of route of administration amongst all clients with hypnotics and sedatives as primary drug
TDI	TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006 Part (i) Percentage distribution amongst new outpatient clients
TDI	TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006 Part (ii) Percentage distribution amongst all outpatient clients
TDI	TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006 Part (iii) Percentage distribution amongst new inpatient clients
TDI	TDI-18. Frequency of use of primary drug among new and all outpatient and inpatient clients in 2006 Part (iv) Percentage distribution amongst all inpatient clients
TDI	TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006 Part (i) New clients entering outpatient treatment
TDI	TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006 Part (ii) All clients entering outpatient treatment
TDI	TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006 Part (iii) New clients entering inpatient treatment
TDI	TDI-19. Percentage distribution of primary drug among new and all clients entering outpatient and inpatient treatment in 2006 Part (iv) All clients entering inpatient treatment
TDI	TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population Part (i) New clients entering outpatient treatment
TDI	TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population Part (ii) All clients entering outpatient treatment
TDI	TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population Part (iii) New clients entering inpatient treatment
TDI	TDI-20. Unemployment rates among new and all clients entering outpatient and inpatient treatment in 2006 and in the general population Part (iv) All clients entering inpatient treatment
TDI	TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 Part (i) Ratio of males to females among new clients entering outpatient treatment
TDI	TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 Part (ii) Ratio of males to females among all clients entering outpatient treatment
TDI	TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 Part (iii) Ratio of males to females among new clients entering inpatient treatment
TDI	TDI-21. Gender ratio by primary drug — ratio of males to females among new and all clients entering outpatient and inpatient treatment in 2006 Part (iv) Ratio of males to females among all clients entering inpatient treatment
TDI	TDI-22. Secondary drugs: number of citations by all clients in outpatient and inpatient centres in 2006: average for those EU countries supplying data Part (i) Outpatient centres
TDI	TDI-22. Secondary drugs: number of citations by all clients in outpatient and inpatient centres in 2006: average for those EU countries supplying data Part (ii) Inpatient centres
TDI	TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type Part (i) Percentage distribution of secondary drug by primary drug for the EU overall
TDI	TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type Part (ii) All clients with opioids as primary drug type: number of episodes reporting the stated drug as secondary
TDI	TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type Part (iii) All clients with cocaine as primary drug type: number of episodes reporting the stated drug as secondary
TDI	TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type Part (iv) All clients with cannabis as primary drug: number of episodes reporting the stated drug as secondary
TDI	TDI-23. Polydrug use among all clients entering outpatient treatment, for countries supplying data for 2006: opioids, cocaine, cannabis or other stimulants as primary drug type combined with a secondary drug type Part (v) All clients with stimulants other than cocaine as primary drug type: number of episodes reporting the stated drug as secondary
TDI	TDI-24. Percentage of clients by type of treatment centres and by primary drug for all and new clients entering treatment in 2006 (outpatient, inpatient and other types of treatment centres) Part (i) All clients
TDI	TDI-24. Percentage of outpatient and inpatient clients by primary drug for all and new clients entering treatment in 2006 Part (ii) New clients
TDI	TDI-25. Percentage distribution of age by gender among all clients entering outpatient treatment with primary drug: opioids, cocaine, stimulants and cannabis in 2006 for countries supplying data
TDI	TDI-32. Mean age by gender by primary drug among all clients entering outpatient and inpatient treatment in 2006 Part (i) Outpatient clients
TDI	TDI-32. Mean age by gender by primary drug among all clients entering outpatient and inpatient treatment in 2006 Part (ii) Inpatient clients
TDI	TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2006 Part (i) Outpatient treatment centres
TDI	TDI-33. Mean age at first use and mean age at entering treatment by gender and primary drug among new clients entering outpatient and inpatient treatment in 2006 Part (ii) Inpatient treatment centres
TDI	TDI-34. Outpatient and inpatient treatment centres and treatment units in prison: number of all clients entering treatment and number and percentages of units covered in four countries supplying data in 2006
TDI	TDI-35. Outpatient and inpatient treatment centres and treatment units in prison: percentage distribution of all clients by primary drug in four countries supplying data in 2006
TDI	TDI-36. Trends in primary amphetamines use among new clients entering treatment between 2001 and 2006 in four countries
TDI	TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006 Part (i) Outpatient and inpatient clients entering treatment for primary amphetamines and ecstasy use in 2006
TDI	TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006 Part (ii) Mean age and gender ratio among primary amphetamines or ecstasy clients entering treatment in 2006
TDI	TDI-37. Amphetamines and ecstasy clients entering drug treatment in 2006 Part (iii) Secondary drugs among outpatient and inpatient clients entering treatment for primary amphetamines and ecstasy use (number of citations)
TDI	TDI-38. All clients in treatment (treatment prevalence) for primary use of amphetamines, ecstasy and other stimulants (other than cocaine) in countries reporting in 2006: demographics and patterns of drug use
TDI	TDI-39. Treatment prevalence in 2006 in nine countries: percentage distribution of all treatment clients by primary drug at treatment entry (first treatment incidence, total treatment incidence, total treatment prevalence)
TDI	TDI-40. Treatment Prevalence in 2006: proportion of injectors by primary drug (excluding cannabis) among treated clients in 2006 in nine countries (first treatment incidence, total treatment incidence, total treatment prevalence)
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(i) Number of clients using opioids as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iv) Number of clients using hallucinogens as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-102. New clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(i) Number of clients using opioids as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iv) Number of clients using hallucinogens as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-103. All clients entering outpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(i) Number of clients using opioids as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iv) Number of clients using hallucinogens as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-104. New clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(i) Number of clients using opioids as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(ii) Number of clients using cocaine (HCl and 'crack') as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part(iv) Number of clients using hallucinogens as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-105. All clients entering inpatient treatment: age and primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (ii) Number of clients using cocaine as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iv) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hallucinogens as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-106. New clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (ii) Number of clients using cocaine as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iv) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hallucinogens as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-107. All clients entering outpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (i) Number of clients using opioids as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (ii) Number of clients using cocaine as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iv) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hallucinogens as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile/inhalants as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-108. New clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (i) Number of clients using opiates as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (ii) Number of clients using cocaine as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iii) Number of clients using stimulants (other than cocaine) as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (iv) Number of clients using hypnotics and sedatives as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (v) Number of clients using hallucinogens as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vi) Number of clients using volatile inhalants as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (vii) Number of clients using cannabis as primary drug
TDI	TDI-109. All clients entering inpatient treatment: age at first use of primary drug at treatment in 2006 for those countries supplying data Part (viii) Number of clients using other drugs as primary drugs
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (i) Percentage distribution amongst new clients with opioids as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (ii) Percentage distribution amongst all clients with opioids as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (iii) Percentage distribution amongst new clients with cannabis as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (iv) Percentage distribution amongst all clients with cannabis as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (v) Percentage distribution amongst new clients with amphetamines and MDMA as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (vi) Percentage distribution amongst all clients with amphetamines and MDMA as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (vii) Percentage distribution amongst new clients with cocaine as primary drug
TDI	TDI-111. Frequency of use of primary drug among new and all outpatient clients in 2006 Part (viii) Percentage distribution amongst all clients with cocaine as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (i) Percentage distribution amongst new clients with opioids as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (ii) Percentage distribution amongst all clients with opioids as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (iii) Percentage distribution amongst new clients with cannabis as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (iv) Percentage distribution amongst all clients with cannabis as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (v) Percentage distribution amongst new clients with amphetamines and MDMA as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (vi) Percentage distribution amongst all clients with amphetamines and MDMA as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (vii) Percentage distribution amongst new clients with cocaine as primary drug
TDI	TDI-112. Frequency of use of primary drug among new and all inpatient clients in 2006 Part (viii) Percentage distribution amongst all clients with cocaine as primary drug
TDI	TDI-113. All clients entering treatment for opioids by type of opioid misused for countries supplying data in 2006
TDI	TDI-114. Primary opioids distribution (percent) among all clients entering treatment by type of treatment centre in three countries supplying data in 2006
TDI	TDI-115. Primary cocaine use – HCL and Crack – among new and all clients entering outpatient drug treatment in 2006 for countries supplying data Part (i) All clients
TDI	TDI-115. Primary cocaine use – HCL and Crack – among new and all clients entering outpatient drug treatment in 2006 for countries supplying data Part (ii) New clients